Minimally Invasive Surgery for Gastric Cancer: Is There a Benefit to Our Patients?
Earlier detection for gastric cancer is becoming possible and attention is finally on our younger patients, whose incidence is increased. Read more... Read More
Efforts Continue to Optimize Immunotherapy in Gastric Cancer
Want an immunotherapy refresher? Check out this recent presentation on immunotherapy in gastric cancer in OncLive.
Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ASCO 2018 Gastrointestinal Cancers Symposium
Encouraging phase 1 results were shared at ASCO for DS-8201 (an antibody drug conjugate) treatment for HER2-positive gastric cancer.
Biomarkers may help predict outcomes in gastric cancer patients who abuse alcohol
A recent study in The American Journal of Pathology on alcohol abuse and gastric cancer finds biomarkers may help predict patient outcomes... Read More
Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium
At ASCO this weekend, new data was shared from a clinical trial of margetuximab and pembrolizumab for patients with advanced gastric cancer,... Read More
Immune Checkpoint Inhibition in Esophagogastric Cancers
An article in Targeted Oncology reviews the treatment strategy that’s changing the treatment landscape for gastric cancer: immunotherapy.
FDA Approvals in RCC and CML, Priority Review Designations in NSCLC and RCC, and More
The European Union’s Committee for Medicinal Products for Human Use (CHMP) recommends the approval of Herzuma, a trastuzumab biosimilar, for treating HER2-positive... Read More
BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers
New research in Human Pathology finds BRCA1 and BRCA2 can be used as clinicopathological biomarkers to assess the prognosis of gastric cancer.
Early Palliative Care Improves QOL for Lung and GI Cancer Patients
A new study in the Journal of Clinical Oncology finds early palliative care leads to enhanced coping strategies and improved quality of... Read More
Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Advanced Gastric Cancer
A new phase 2 study in Japan and South Korea will evaluate the efficacy and safety of DS-8201 in ER2-expressing gastric cancer.